Dose to bone marrow using IMRT techniques in prostate cancer patients.

Published on Mar 1, 2005in Strahlentherapie Und Onkologie2.899
· DOI :10.1007/S00066-005-1360-4
Eduard Gershkevitsh6
Estimated H-index: 6
,
Catharine H. Clark26
Estimated H-index: 26
(The Royal Marsden NHS Foundation Trust)
+ 2 AuthorsKlaus-Rüdiger Trott11
Estimated H-index: 11
(Lond: University of London)
Sources
Abstract
Dose to bone marrow using IMRT techniques in prostate cancer patients Purpose: To investigate the dose distribution in active bone marrow of patients undergoing intensity-modulated radiotherapy (IMRT) for prostate cancer and compare it to the distribution in the same patients, if they had been treated using conformal plans, in order to develop criteria for optimization to minimize the estimated risk of secondary Leukemia. Patients and Methods: Mean bone marrow doses were calculated for ten patients with Localized prostate cancer who underwent whole- pelvis IMRT and compared to three-dimensional conformal (3-D CRT) plans prepared for the same patients. Also for comparison, the IMRT and 3-D CRT plans were produced to simulate the treatment of the prostate gland only. To measure the dose to extrapelvic bone marrow, three thermoluminescent diode (TLD) chips were placed in the middle of the sternum region inside the Rando phantom. Results: For both the pelvic and prostate- only volumes, the IMRT plans were superior to 3-D CRT plans in reducing the high dose volume to the rectum, the bladder and the small bowel while maintaining acceptable coverage of the planning target volume (PTV). For the pelvic treatment group the IMRT plans, compared to 3-D CRT, reduced the high dose volume (> 20 Gy) to os coxae, which is the main contributor of dose to pelvic bone marrow, but increased the middle dose volume (10-20 Gy). No statistically significant differences were observed for Lower dose volumes ( 10 Gy. The number of monitor units needed to deliver an IMRT plan affects Leakage dose and their incorporation into planning constraints should be considered.
📖 Papers frequently viewed together
730 Citations
9 Citations
References16
Newest
#1Razvan GalalaeH-Index: 17
#2Tillmann LochH-Index: 15
Last. György KovácsH-Index: 22
view all 7 authors...
Purpose: To report long-term outcomes in terms of health-related quality of life (HRQoL) and survival of a dose-escalating radiotherapy protocol and to validate a new disease-specific HRQoL instrument. Patients and Methods: 189 consecutive men with prostate cancer were analyzed; 127 patients had T1-2 (1% T1, 66% T2) and 62 patients (33%) T3 tumors. The pelvic lymphatics were treated to a dose of 50 Gy by external-beam irradiation. The prostate dose was limited to 40 Gy using compensators. The pr...
28 CitationsSource
#1Gert De Meerleer (UGent: Ghent University)H-Index: 12
#2Luc Vakaet (UGent: Ghent University)H-Index: 9
Last. Wilfried De Neve (UGent: Ghent University)H-Index: 59
view all 5 authors...
Background and Purpose: To describe the implementation and to evaluate the results of direct segment aperture optimization using the segment outline and weight adapting tool (SOWAT) in intensity-modulated radiotherapy (IMRT) for prostate cancer. Patients and Methods: 14 consecutive, unselected patients with localized prostate cancer were entered in a planning study comparing IMRT without and with the use of SOWAT. The clinical target volume (CTV) consisted of the prostate and seminal vesicles in...
47 CitationsSource
#1Giuseppe SanguinetiH-Index: 37
#2Paola FranzoneH-Index: 14
Last. Vito VitaleH-Index: 25
view all 5 authors...
Purpose: To assess whether the topical use of steroids or 5-aminosalicylic acid (5-ASA) is superior to sucralfate in preventing acute rectal toxicity during three-dimensional conformal radiotherapy (3DCRT) to 76 Gy. Patients and Methods: Patients undergoing 3DCRT for prostate carcinoma at our institution were offered to be randomized to sucralfate 3 g in 15 ml suspension enema (Antepsin®), mesalazine 4 g gel enema (Enterasyn®), or hydrocortisone 100 mg foam enema (Colifoam®). Randomization was b...
48 CitationsSource
#1Gregor Goldner (University of Vienna)H-Index: 26
Last. Richard Pötter (University of Vienna)H-Index: 31
view all 6 authors...
Background: Radiotherapy-induced side effects are often scored retrospectively according to the EORTC/RTOG scores for organs at risk by reviewing the medical records. Some studies could prove an over- or underestimation of side effects as assessed by the medical professionals. The aim of this study was to prospectively evaluate differences in side effects as described by the doctors and the patients. Patients and Methods: 47 patients with prostate cancer were questioned about their side effects ...
50 CitationsSource
#1Eric J. Hall (Columbia University)H-Index: 79
#2Cheng-Shie Wuu (Columbia University)H-Index: 14
Abstract Information concerning radiation-induced malignancies comes from the A-bomb survivors and from medically exposed individuals, including second cancers in radiation therapy patients. The A-bomb survivors show an excess incidence of carcinomas in tissues such as the gastrointestinal tract, breast, thyroid, and bladder, which is linear with dose up to about 2.5 Sv. There is great uncertainty concerning the dose– response relationship for radiation-induced carcinogenesis at higher doses. So...
1,006 CitationsSource
Abstract Background and purpose : To describe the risk of second malignancy following a diagnosis of prostate cancer, in British Columbia (BC), Canada. To ascertain whether that risk changed with the use of radiation therapy. Methods and materials : All invasive cases of prostate cancer diagnosed from 1984 through to 2000 were retrieved from the BC Tumor Registry. Standardized incidence ratios (SIRs) were calculated from observed and expected numbers as a percentage. Patients were divided into t...
114 CitationsSource
#1Wolfgang Dörr (TUD: Dresden University of Technology)H-Index: 38
#2Thomas Herrmann (TUD: Dresden University of Technology)H-Index: 21
The aim of the present analysis was to identify radiotherapy-related parameters that influence the development of second malignancies.
94 CitationsSource
#1Eduard Gershkevitsh (UT: University of Tartu)H-Index: 1
#2Guido Hildebrandt (Leipzig University)H-Index: 40
Last. Klaus-Rüdiger Trott (QMUL: Queen Mary University of London)H-Index: 11
view all 6 authors...
Radiotherapy plays an important role in the management of prostate cancer. Epidemiological data indicate a small but sinificant risk of radiation-induced leukemia after radiotherapy which might be related to the high mean bone marrow dose associated with radiotherapy of prostate cancer. The purpose of the study was to investigate the relation between the mean bone marrow dose and unstable chromosome aberrations in peripheral blood lymphocytes in patients undergoing conformal radiotherapy for pro...
12 CitationsSource
#1Christopher M. Nutting (The Royal Marsden NHS Foundation Trust)H-Index: 69
#2David J Convery (The Royal Marsden NHS Foundation Trust)H-Index: 9
Last. David P. Dearnaley (The Royal Marsden NHS Foundation Trust)H-Index: 108
view all 7 authors...
Abstract Purpose: To investigate the role of intensity-modulated radiation therapy (IMRT) to irradiate the prostate gland and pelvic lymph nodes while sparing critical pelvic organs, and to optimize the number of beams required. Methods and Materials: Target, small bowel, colon, rectum, and bladder were outlined on CT planning scans of 10 men with prostate cancer. Optimized conventional (RT) and 3-dimensional conformal radiotherapy (3D-CRT) plans were created and compared to inverse-planned IMRT...
208 CitationsSource
#1Eduard Gershkevitsh (UT: University of Tartu)H-Index: 6
#2Ivan RosenbergH-Index: 4
Last. Klaus-Rüdiger Trott (QMUL: Queen Mary University of London)H-Index: 11
view all 4 authors...
Abstract Background and purpose : As more and more patients with prostate cancer are cured and survive with only minor chronic morbidity, other potentially treatment related morbidity, in particular second cancers, becomes an urgent problem which may influence decisions on treatment strategy and treatment plan optimisation. Epidemiological data suggest a radiotherapy associated risk of AML in prostate cancer patients of approximately 0.1% in 10 years. The aim of the study was to determine the ra...
21 CitationsSource
Cited By30
Newest
#1Carola HartelH-Index: 4
#2Elena Nasonova (JINR: Joint Institute for Nuclear Research)H-Index: 15
Last. Sylvia RitterH-Index: 18
view all 6 authors...
Abstract Background and purpose Chromosomal aberrations in peripheral blood lymphocytes are a biomarker for radiation exposure and are associated with an increased risk for malignancies. To determine the long-term cytogenetic effect of radiotherapy, we analyzed the persistence of different aberration types up to 2.5 years after the treatment. Materials and methods Cytogenetic damage was analyzed in lymphocytes from 14 patients that had undergone C-ion boost + IMRT treatment for prostate cancer. ...
3 CitationsSource
#1Chenyang Wang (UCLA: University of California, Los Angeles)H-Index: 7
#2Christopher R. King (UCLA: University of California, Los Angeles)H-Index: 37
Last. Michael L. Steinberg (UCLA: University of California, Los Angeles)H-Index: 26
view all 8 authors...
Abstract Background and purpose Second malignancies (SM) after external beam radiotherapy (EBRT) or brachytherapy (BT) for prostate cancer (PCa) are rare but serious sequelae. Materials and methods The Surveillance, Epidemiology, and End Results (SEER) database was used to identify men diagnosed with cT1-2N0M0 PCa between 1999 and 2005, who underwent EBRT, BT or radical prostatectomy (RP). Patients with time interval to second malignancy or follow-up shorter than five and two years were excluded...
11 CitationsSource
#1Jun Yuan (CSU: Central South University)H-Index: 1
#2Mingjun Lei (CSU: Central South University)H-Index: 1
Last. Jidong Hong (CSU: Central South University)H-Index: 3
view all 6 authors...
The aim of the present study was to evaluate the difference in treatment plan quality, monitor units (MUs) per fraction and dosimetric parameters between IMRT (intensity-modulated radiotherapy) and RapidArc with single arc (RA1) and dual arc (RA2) for malignant glioma involving the parietal lobe. Treatment plans for IMRT and RA1 and RA2 were prepared for 10 patients with malignant gliomas involving the parietal lobe. The Wilcoxon matched-pair signed-rank test was used to compare the plan quality...
3 CitationsSource
#1Jianyang WangH-Index: 5
#2Yuan Tian (Peking Union Medical College)H-Index: 5
Last. Jing JinH-Index: 38
view all 14 authors...
Purpose: This study aimed to spare hematopoietical bone marrow (BM) identified by magnetic resonance (MR) radiation in order to alleviate acute hematologic toxicity (HT) for gastric cancer patients treated with postoperative chemoradiotherapy (CRT). Methods: A prospective, open-label, single-arm Phase II study (Clinicaltrials.gov; NCT 01863420) was conducted in 25 patients with gastric cancer who were eligible for postoperative concurrent CRT. The MR images of vertebral body T8-L4 were fused wit...
4 CitationsSource
#1Wang Jianyang (Peking Union Medical College)H-Index: 1
#2Tian Yuan (Peking Union Medical College)H-Index: 1
Last. Song Yongwen (Peking Union Medical College)H-Index: 2
view all 14 authors...
Purpose To reduce acute hematologic toxicity (HT) in rectal cancer patients treated with neoadjuvant concurrent chemoradiotherapy by sparing the hematopoietical bone marrow (BM) indentified by magnetic resonance (MR).
9 CitationsSource
Abstract This study evaluated the secondary cancer risk from volumetric-modulated arc therapy (VMAT) for spine radiotherapy compared with intensity-modulated radiotherapy (IMRT) and 3-dimensional conformal radiotherapy (3DCRT). Computed tomography images of an Radiological Physics Center spine anthropomorphic phantom were exported to a treatment planning system (Pinnacle 3 , version 9.4). Radiation treatment plans for spine were prepared using VMAT (dual-arc), 7-field IMRT (beam angles: 110°, 13...
9 CitationsSource
#1Martin Dolezel (Charles University in Prague)H-Index: 9
#2Karel Odrazka (Charles University in Prague)H-Index: 11
Last. Josef Kovarik (Freeman Hospital)H-Index: 6
view all 10 authors...
Purpose The purpose of this work was to compare toxicity and cancer control between patients with prostate cancer treated using three-dimensional conformal radiotherapy (3D-CRT) and those treated using intensity-modulated radiation therapy (IMRT).
26 CitationsSource
#1Jinqin Ai (HUST: Huazhong University of Science and Technology)H-Index: 1
#2Tianwu Xie (HUST: Huazhong University of Science and Technology)H-Index: 10
Last. Qian Liu (HUST: Huazhong University of Science and Technology)H-Index: 65
view all 4 authors...
Red bone marrow (RBM) is an important dose-limiting tissue that has high radiosensitivity but is difficult to identify on clinical medical images. In this study, we investigated dose distribution in RBM for prostate cancer radiotherapy. Four suborgans were identified in the skeleton of the visible Chinese human phantom: cortical bone (CB), trabecular bone (TB), RBM, and yellow bone marrow (YBM). Dose distributions in the phantom were evaluated by the Monte Carlo method. When the left os coxae wa...
2 CitationsSource
#1M. Teoh (Royal Surrey County Hospital)H-Index: 1
#2Catharine H. ClarkH-Index: 26
Last. Andrew NisbetH-Index: 32
view all 5 authors...
Volumetric modulated arc therapy (VMAT) is a novel radiation technique, which can achieve highly conformal dose distributions with improved target volume coverage and sparing of normal tissues compared with conventional radiotherapy techniques. VMAT also has the potential to offer additional advantages, such as reduced treatment delivery time compared with conventional static field intensity modulated radiotherapy (IMRT). The clinical worldwide use of VMAT is increasing significantly. Currently ...
359 CitationsSource
#1Daniel A. Low (WashU: Washington University in St. Louis)H-Index: 69
#2Jean M. Moran (UM: University of Michigan)H-Index: 31
Last. Mark Oldham (Duke University)H-Index: 43
view all 5 authors...
Intensity modulated radiation therapy (IMRT) poses a number of challenges for properly measuring commissioning data and quality assurance (QA) radiation dose distributions. This report provides a comprehensive overview of how dosimeters, phantoms, and dose distribution analysis techniques should be used to support the commissioning and quality assurance requirements of an IMRT program. The proper applications of each dosimeter are described along with the limitations of each system. Point detect...
297 CitationsSource